Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination

Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination

Abstract In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes, challenges, and future directions f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jessica Presa, Ruth Carrico, Jaime E. Fergie, Stephanie Hanenberg, Gary S. Marshall, Kaitlyn Rivard, Jana Shaw, Gregory D. Zimet, Paula Peyrani, Alejandro Cane
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-06-01
Series:	Infectious Diseases and Therapy
Subjects:	Adolescents Healthcare providers Invasive meningococcal disease MenABCWY vaccine Public health policy Shared clinical decision-making
Online Access:	https://doi.org/10.1007/s40121-025-01166-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025
by: Shamez N Ladhani
Published: (2025-08-01)

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children
by: Federico Martinón-Torres, et al.
Published: (2025-04-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial
by: Federico Martinon-Torres, et al.
Published: (2025-07-01)

Unusual course of meningococcal infection with lethal outcome (brief communication)
by: V. A. Zinserling, et al.
Published: (2023-07-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Meningococcal Carriage: Epidemiology, Causative Agent, Inducing of Immune Protection
by: N. N. Kostyukova, et al.
Published: (2017-10-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Primary (isolated) meningococcal pericarditis caused by <i>N. meningitidis</i>: case report
by: O. O. Chernysheva, et al.
Published: (2025-03-01)

Meningococcal meningitis complicated by septic shock, myocarditis and purpura fulminans
by: H. M. U. A. S. Perera, et al.
Published: (2025-08-01)

Meningococcal infection in children in the period 2012–2021. Main results of a retrospective multicenter study, issues of the day
by: A. A. Vilnits, et al.
Published: (2024-01-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

Epidemiology of invasive meningococcal disease in Novosibirsk region during 1992–2015
by: I. Ya. Izvekova, et al.
Published: (2016-11-01)

Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus
by: E. N. Sergienko, et al.
Published: (2024-01-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

Clinical and epidemiological characteristics of meningococcal infection morbidity in Penza Region for the period 2007-2019
by: V. L. Melnikov, et al.
Published: (2021-10-01)

CLINICAL-EPIDEMIOLOGICAL FEATURES AND OUTCOME OF GENERALIZED FORMS OF MENINGOCOCCAL INFECTION IN CHILDREN
by: G. P. Martynova, et al.
Published: (2017-10-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Systemic meningococcal disease in children: survival analysis, Arkhangelsk region, Northwest Russia, 1991–2011
by: O. V. Samodova, et al.
Published: (2014-09-01)

Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines
by: Laurent Coudeville, et al.
Published: (2025-07-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

Rare generalized form of meningococcal disease caused by Neisseria meningitidis serogroup W
by: L. N. Mazankova, et al.
Published: (2020-03-01)

Systemic meningococcal infection in children of the Arkhangelsk region: predictors of unfavorable course and outcome during different periods of observation
by: O. V. Samodova, et al.
Published: (2024-09-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)
by: V. V. Sharabkhanov, et al.
Published: (2020-06-01)

Epidemiological characteristics of invasive meningococcal disease and carriage prevalence of Neisseria meningitidis in the Xinjiang Uygur Autonomous Region, China, 2004–2023: a retrospective study
by: Halimubieke Nazhaerbieke, et al.
Published: (2025-07-01)

“And All These Prejudices That Exist, I Think I Also Fall For That” Healthcare Providers’ Perceptions of Interacting With Patients in a Low Socioeconomic Position
by: Kim Tenfelde, et al.
Published: (2025-06-01)

Meningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databases
by: Rafael Ruiz-Montero, et al.
Published: (2025-03-01)

Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada
by: Todd Wolynn, et al.
Published: (2025-07-01)

Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges
by: N. N. Kostyukova, et al.
Published: (2016-08-01)

Benefits and risks of health data reuse for healthcare providers: stakeholder perspectives from a qualitative interview study
by: Susanne Stark, et al.
Published: (2025-03-01)

The development and certification of the industrial reference standard for identification of meningococcal polysaccharide vaccine group A
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Loneliness and Intersectional Discrimination Among Aging LGBT People in Spain: A Qualitative Research Study of Gay Men
by: Sacramento Pinazo-Hernandis, et al.
Published: (2025-06-01)

Molecular Сharacterization of <i>Neisseria meningitidis</i> Serogroup W in St. Petersburg
by: E. A. MARTENS, et al.
Published: (2022-09-01)

Googling concussion care in the USA: a critical appraisal of online concussion healthcare providers
by: Michael J Ellis, et al.
Published: (2017-06-01)

Travel vaccines: information for health care workers
by: Natalie Schellack, et al.
Published: (2017-05-01)

The effect of batched patient–physician assignment on patient length of stay in the emergency department
by: Bryan Imhoff, et al.
Published: (2022-08-01)